| 1336960-13-4 Basic information More.. |
Product Name: | 3-([1,4′-Bipiperidin]-1′-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide | Synonyms: | 3-([1,4′-Bipiperidin]-1′-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide;GSK2193874;TRPV4 antagonist GS2193874;GSK 2193874; GSK2193874;4-Quinolinecarboxamide, 3-([1,4'-bipiperidin]-1'-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-;GSK2193874 >=98% (HPLC);GSK2193874,inhibit,GSK 2193874,Transient receptor potential channels,GSK-2193874,Inhibitor,TRP Channel;3-([1,4'-Bipiperidin]-1'-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxamide | CAS: | 1336960-13-4 | MF: | C37H38BrF3N4O | MW: | 691.62 | EINECS: | | Mol File: | Mol File | |
|
1336960-13-4 Recommend
Suppliers |
|
|
Recommend You Select Member Companies. |
|
|